{"retracted":false,"update":{"timestamp":1447977600000,"doi":"10.1007/s00280-015-2890-9","type":"correction"},"doi":"10.1007/s00280-015-2850-4","journal":"Cancer Chemotherapy and Pharmacology","publisher":"Springer Nature","title":"Erratum to: Phase 1 study of oral TAS-102 in patients with refractory metastatic colorectal cancer"}
